Two Queen's profs part of national ovarian cancer initiative
2011 October 13
Queen's University professors are part of a
new pan-Canadian initiative that aims to change the way
ovarian cancer is diagnosed and managed.
Janet Dancey and Jeremy Squire
are among the 35 investigators from across Canada taking part in COEUR,
a five-year, multi-site program that will identify new biomarkers to
predict and treat the relatively rare but deadly form of cancer.
"This project is tremendously important for identifying markers for
early diagnosis and for improved treatment options for patients with
ovarian cancer," says Dr. Dancey, a professor in the Department of
Oncology and a medical oncologist at Kingston General Hospital.
The team's work will help clinicians better determine what
treatment will work best for each patient. Patients who do not
respond to standard therapy can be directed to clinical trials
where new therapies are being validated.
"It is a privilege to be part of this extraordinary national effort,"
says Dr. Squire, a professor in the Department of Pathology and
Molecular Medicine and doctor at Kingston General Hospital.
"We all believe this project will contribute enormously to
relieving the burden of ovarian cancer."
The Terry Fox Research Institute (TFRI) initiative, and
the Canadian Partnership Against Cancer are providing a
total of $5-million in funding for the program.
The NCIC Clinical Trials Group at Queen's is also collaborating on